MTOR and ovarian cancer: Furthermore, UBE2S might accelerate the cell cycle and inhibit apoptosis by promoting PI3K/AKT/mTOR and ultimately drive the malignant biological behavior of OV cells, which may provide new ideas for prognostic evaluation and molecular therapy of ovarian cancer.